Literature DB >> 17061535

[Antimicrobial mechanisms and potential clinical application of lactoferrin].

Dora Alicia Rodríguez-Franco1, Luz Vázquez-Moreno, Gabriela Ramos-Clamont Montfort.   

Abstract

Lactoferrin (Lf) is an iron binding multifunctional glycoprotein that is present in several mucosal secretions like milk, tears and saliva. Lf is also an abundant component of the specific granules of neutrophils and can be released into the serum upon neutrophil degranulation. One of the functions of this protein is the transport of metals, but it is also an important component of the non-specific immune system. Human and bovine Lfs display a broad antimicrobial spectrum against Gram positive and Gram negative bacteria, fungi and several viruses. While the iron-binding properties were originally believed to be solely responsible for the host defense properties ascribed to lactoferrin, it is now known that other mechanisms contribute to the antimicrobial role of this glycoprotein. This review gives an overview of the knowledge of these mechanisms and the potential clinical applications of Lf against infections

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 17061535

Source DB:  PubMed          Journal:  Rev Latinoam Microbiol        ISSN: 0187-4640


  9 in total

1.  p38MAPK, ERK and PI3K signaling pathways are involved in C5a-primed neutrophils for ANCA-mediated activation.

Authors:  Jian Hao; Li-Qiang Meng; Peng-Cheng Xu; Min Chen; Ming-Hui Zhao
Journal:  PLoS One       Date:  2012-05-31       Impact factor: 3.240

2.  High mobility group box 1 contributes to anti-neutrophil cytoplasmic antibody-induced neutrophils activation through receptor for advanced glycation end products (RAGE) and Toll-like receptor 4.

Authors:  Chen Wang; Huan Wang; Dong-Yuan Chang; Jian Hao; Ming-Hui Zhao; Min Chen
Journal:  Arthritis Res Ther       Date:  2015-03-18       Impact factor: 5.156

3.  In silico investigation of lactoferrin protein characterizations for the prediction of anti-microbial properties.

Authors:  Seyyed Mohsen Sohrabi; Ali Niazi; Mahmood Chahardoli; Ali Hortamani; Payam Setoodeh
Journal:  Mol Biol Res Commun       Date:  2014-06

4.  Potential of lactoferrin to prevent antibiotic-induced Clostridium difficile infection.

Authors:  C H Chilton; G S Crowther; K Śpiewak; M Brindell; G Singh; M H Wilcox; T M Monaghan
Journal:  J Antimicrob Chemother       Date:  2016-01-11       Impact factor: 5.790

5.  Bacterial biota of women with bacterial vaginosis treated with lactoferrin: an open prospective randomized trial.

Authors:  Alessandra Pino; Giuliana Giunta; Cinzia L Randazzo; Salvatore Caruso; Cinzia Caggia; Antonio Cianci
Journal:  Microb Ecol Health Dis       Date:  2017-01-01

6.  HMGB1 contributes to glomerular endothelial cell injury in ANCA-associated vasculitis through enhancing endothelium-neutrophil interactions.

Authors:  Chen Wang; Dong-Yuan Chang; Min Chen; Ming-Hui Zhao
Journal:  J Cell Mol Med       Date:  2017-02-09       Impact factor: 5.310

Review 7.  Lactoferrin a multiple bioactive protein: an overview.

Authors:  Isui Abril García-Montoya; Tania Siqueiros Cendón; Sigifredo Arévalo-Gallegos; Quintín Rascón-Cruz
Journal:  Biochim Biophys Acta       Date:  2011-06-25

Review 8.  Lactoferrin from Milk: Nutraceutical and Pharmacological Properties.

Authors:  Francesco Giansanti; Gloria Panella; Loris Leboffe; Giovanni Antonini
Journal:  Pharmaceuticals (Basel)       Date:  2016-09-27

Review 9.  Potential Protective Protein Components of Cow's Milk against Certain Tumor Entities.

Authors:  Christian Leischner; Sarah Egert; Markus Burkard; Sascha Venturelli
Journal:  Nutrients       Date:  2021-06-08       Impact factor: 5.717

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.